Phillip Seligman
Standard & Poor's
Recent Quotes
"We see growth opportunities for ALGN in emerging markets."
—
Phillip Seligman, Standard & Poor's
(12/18/12)
more >
"For MDT's FY/13 (April), we expect total sales to rise by 1.9%."
—
Phillip Seligman, Standard & Poor's
(11/28/12)
more >
"We see growth opportunities for ALGN in emerging markets."
—
Phillip Seligman, Standard & Poor's
(7/25/12)
more >
"We have upgraded ALGN's rating to Buy based on its promising growth prospects."
—
Phillip Seligman, Standard & Poor's
(6/23/12)
more >
"We look for ISRG's sales to rise by about 22% in 2012."
—
Phillip Seligman, Standard & Poor's
(6/23/12)
more >
"We expect ALGN to continue to fuel demand with new products."
—
Phillip Seligman, Standard & Poor's
(6/16/12)
more >
"We forecast revenue growth of 18% in 2012 for EW."
—
Phillip Seligman, Standard & Poor's
(5/12/12)
more >
"ISRG's da Vinci system based procedures should grow 25–27% in 2012."
—
Phillip Seligman, Standard & Poor's
(5/5/12)
more >
